Joshua Foukas, Chief Legal Officer of Usana Health Sciences (NASDAQ: USNA), sold 4,461 shares of common stock for approximately $95,220. Following the sale, Foukas directly holds zero shares, but was granted 36,662 restricted stock units which vest quarterly starting February 19, 2026. This comes as the company projects 2025 net sales of $925 million and 2026 revenues between $925 million and $1 billion, alongside an extended partnership with the Jamaica Bobsleigh and Skeleton Federation.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Usana Health Sciences: Chief legal officer Foukas sells $95k in shares
Joshua Foukas, Chief Legal Officer of Usana Health Sciences (NASDAQ: USNA), sold 4,461 shares of common stock for approximately $95,220. Following the sale, Foukas directly holds zero shares, but was granted 36,662 restricted stock units which vest quarterly starting February 19, 2026. This comes as the company projects 2025 net sales of $925 million and 2026 revenues between $925 million and $1 billion, alongside an extended partnership with the Jamaica Bobsleigh and Skeleton Federation.